The challenges and trends of cell & gene therapies
Drug Discovery World
SEPTEMBER 6, 2022
DDW Editor Reece Armstrong looks at the cell and gene therapy landscape, examining the challenges facing developers and the trends we can expect to see throughout the year. . For cell and gene therapies, Covid-19 was a “double-edged sword”, according to Kristin Thompson, Chief Business Officer at eureKARE.
Let's personalize your content